Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokoi, K.
Right arrow Articles by Tominaga, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokoi, K.
Right arrow Articles by Tominaga, K.
(Chest. 1999;115:714-719.)
© 1999 American College of Chest Physicians

Detection of Brain Metastasis in Potentially Operable Non-small Cell Lung Cancer*

A Comparison of CT and MRI

Kohei Yokoi, MD; Noriki Kamiya, MD; Haruhisa Matsuguma, MD; Suguru Machida, MD; Takashi Hirose, MD; Kiyoshi Mori, MD and Keigo Tominaga, MD

* From the Divisions of Thoracic Surgery (Drs. Yokoi, Kamiya, and Matsuguma), and Thoracic Diseases (Drs. Machida, Hirose, Mori, and Tominaga), Tochigi Cancer Center, Utsunomiya, Japan.

Study objective: To compare the usefulness of MRI and CT in the detection of brain metastases during preoperative evaluation and postoperative follow-up.

Design: A prospective and sequential comparison.

Patients and methods: Of 332 patients with potentially operable non-small cell lung cancer who were free of neurologic signs and symptoms, brain CT was performed preoperatively on 155 patients (CT group) and brain MRI on 177 patients (MRI group). Patient characteristics in both groups were comparable. In 279 patients with complete resection of the primary lung tumor, intensive follow-up with CT and MRI was performed in the respective groups. The preoperative detection of brain metastases, postoperative intracranial recurrence rates, and characteristics of detected brain tumors were compared between the two groups. The survival of patients with brain metastases was also compared.

Results: From the first evaluation to 12 months after surgery for primary lung cancer, brain metastases were observed in 11 patients (7.1%) from the CT group and 12 patients (6.8%) from the MRI group. MRI detected brain metastases preoperatively in 6 of the 12 patients (3.4% of the total MRI group), whereas CT detected brain metastases preoperatively in 1 of the 11 patients (0.6% of the total CT group). MRI showed a tendency toward a higher preoperative detection rate of brain metastases than CT (p = 0.069). Furthermore, the mean (± SD) maximal diameter of the brain metastases was significantly smaller in the MRI group (12.8 ± 9.1 mm) than in the CT group (20.3 ± 7.0 mm) (p = 0.041). However, the median survival time and 2-year survival rate after treatment of detected brain metastases, respectively, were 10 months and 27% in the CT group and 17 months and 28% in the MRI group. There was no significant difference between the groups in survival time.

Conclusions: Preoperative evaluation and intensive follow-up with MRI could facilitate early detection of brain metastases in patients with potentially operable lung cancer. However, further studies on detection and treatment of the metastatic tumors are considered necessary.

Key Words: brain metastasis • CT • lung cancer • MRI




This article has been cited by other articles:


Home page
JNMHome page
K. E. Posther, L. M. McCall, D. H. Harpole Jr., C. E. Reed, J. B. Putnam Jr., V. W. Rusch, and B. A. Siegel
Yield of Brain 18F-FDG PET in Evaluating Patients with Potentially Operable Non-Small Cell Lung Cancer
J. Nucl. Med., October 1, 2006; 47(10): 1607 - 1611.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
I.-F. Talos, K. H. Zou, L. Ohno-Machado, J. G. Bhagwat, R. Kikinis, P. M. Black, and F. A. Jolesz
Supratentorial Low-Grade Glioma Resectability: Statistical Predictive Analysis Based on Anatomic MR Features and Tumor Characteristics.
Radiology, May 1, 2006; 239(2): 506 - 513.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al.
American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003
J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353.
[Full Text] [PDF]


Home page
ChestHome page
E. M. Toloza, L. Harpole, and D. C. McCrory
Noninvasive Staging of Non-small Cell Lung Cancer: A Review of the Current Evidence
Chest, January 1, 2003; 123(1_suppl): 137S - 146S.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J.A. Verschakelen, J. Bogaert, and W. De Wever
Computed tomography in staging for lung cancer
Eur. Respir. J., February 1, 2002; 19(35_suppl): 40S - 48s.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Chest Physicians.